Literature DB >> 14671732

The relationship between insight and symptoms in schizophrenia.

Serge Sevy1, Kay Nathanson, Hema Visweswaraiah, Xavier Amador.   

Abstract

We examined the relationship between insight and the positive, negative, active, dysphoric, and autistic dimensions of symptoms in patients with a diagnosis of schizophrenia. Ninety-six patients with a diagnosis of schizophrenia were assessed using the Scale to Assess Unawareness of Mental Disorder, Revised Version (SUMD-R) and the Positive and Negative Syndrome Scale (PANSS). The PANSS data were analyzed based on a five-factor model defined by White et al (1997). The percentage of patients having a lack of awareness was 32.7% for illness, 58.2% for symptoms, 18.4% for treatment response, and 41.8% for social consequences. Lack of awareness of symptoms was significantly correlated with all five symptom factors. Lack of awareness of the illness and its social consequences was only correlated with the positive dimension. Lack of awareness of achieved effects of medication was correlated with the autistic preoccupation factor. There was no correlation between current misattributions for symptoms and PANSS factors. We conclude that poor insight is a common feature of schizophrenia and has a complex relationship to other symptoms of the illness. Our results suggest that (1) unawareness of symptoms is related to severity of illness; (2) insight into illness and its social consequences is more closely tied to positive symptoms than other aspects of insight; and (3) insight into the effects of medication is more closely related to cognitive impairment. Treatment studies that measure insight could answer the question of whether these deficits in awareness improve along with positive and cognitive symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671732     DOI: 10.1016/j.comppsych.2003.09.002

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  14 in total

1.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

Review 2.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

Review 3.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

4.  Differing correlates for suicide attempts among patients with schizophrenia or schizoaffective disorder in India and USA.

Authors:  Triptish Bhatia; Pramod Thomas; Prachi Semwal; B K Thelma; V L Nimgaonkar; Smita N Deshpande
Journal:  Schizophr Res       Date:  2006-06-15       Impact factor: 4.939

5.  A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: a pilot study.

Authors:  Matthew M Kurtz; Elizabeth Baker; Godfrey D Pearlson; Robert S Astur
Journal:  Schizophr Bull       Date:  2006-09-06       Impact factor: 9.306

6.  Insight, cognitive dysfunction and symptomatology in schizophrenia.

Authors:  Luciana C Monteiro; Vanessa A Silva; Mario R Louzã
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

Review 7.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

8.  Which came first, delusions or hallucinations? An exploration of clinical differences among patients with first-episode psychosis based on patterns of emergence of positive symptoms.

Authors:  Michael T Compton; Amy A Potts; Claire Ramsay Wan; Dawn Flosnik Ionescu
Journal:  Psychiatry Res       Date:  2012-08-27       Impact factor: 3.222

9.  Parietal lobes in schizophrenia: do they matter?

Authors:  Murat Yildiz; Stefan J Borgwardt; Gregor E Berger
Journal:  Schizophr Res Treatment       Date:  2011-10-16

10.  Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.

Authors:  José Manuel Olivares; Köksal Alptekin; Jean-Michel Azorin; Fernando Cañas; Vincent Dubois; Robin Emsley; Philip Gorwood; Peter M Haddad; Dieter Naber; George Papageorgiou; Miquel Roca; Pierre Thomas; Guadalupe Martinez; Andreas Schreiner
Journal:  Patient Prefer Adherence       Date:  2013-01-30       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.